AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 37 filers reported holding AGILE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,210,000 | -3.3% | 1,513,975 | 0.0% | 0.21% | -9.2% |
| Q1 2019 | $2,286,000 | +162.2% | 1,513,975 | 0.0% | 0.23% | +105.4% |
| Q4 2018 | $872,000 | +57.1% | 1,513,975 | 0.0% | 0.11% | +98.2% |
| Q3 2018 | $555,000 | -25.2% | 1,513,975 | 0.0% | 0.06% | -41.7% |
| Q2 2018 | $742,000 | -80.9% | 1,513,975 | 0.0% | 0.10% | -82.6% |
| Q1 2018 | $3,891,000 | -4.5% | 1,513,975 | 0.0% | 0.55% | -36.8% |
| Q4 2017 | $4,073,000 | -39.7% | 1,513,975 | 0.0% | 0.87% | -36.1% |
| Q3 2017 | $6,752,000 | +18.9% | 1,513,975 | 0.0% | 1.36% | -4.5% |
| Q2 2017 | $5,677,000 | +17.0% | 1,513,975 | 0.0% | 1.43% | +0.2% |
| Q1 2017 | $4,852,000 | -43.8% | 1,513,975 | 0.0% | 1.43% | -49.8% |
| Q4 2016 | $8,630,000 | -38.8% | 1,513,975 | -25.0% | 2.84% | -35.3% |
| Q3 2016 | $14,099,000 | -8.3% | 2,019,955 | 0.0% | 4.39% | +4.7% |
| Q2 2016 | $15,372,000 | +22.5% | 2,019,955 | 0.0% | 4.20% | +33.4% |
| Q1 2016 | $12,544,000 | – | 2,019,955 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 4,668,763 | $43,278,000 | 14.12% |
| Aisling Capital LLC | 2,983,797 | $27,660,000 | 3.62% |
| INVESTOR AB | 3,510,189 | $32,539,000 | 2.91% |
| Foresite Capital Management II, LLC | 459,266 | $4,257,000 | 2.52% |
| RA Capital Management | 1,458,792 | $13,523,000 | 1.34% |
| Sio Capital Management, LLC | 203,732 | $1,889,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 80,959 | $750,000 | 0.63% |
| Pinnacle Wealth Management Advisory Group, LLC | 49,623 | $460,000 | 0.41% |
| CAXTON CORP | 26,736 | $248,000 | 0.30% |
| Cormorant Asset Management, LP | 182,053 | $1,688,000 | 0.26% |